AI assistant
EXELIXIS, INC. — Director's Dealing 2024
Nov 8, 2024
30561_dirs_2024-11-07_53bcbbd6-77fa-43e6-a651-5762d6f747d7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2024-11-05
Reporting Person: Aftab Dana (CSO/EVP Disc & Trans Research)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-11-05 | Common Stock | M | 96986 | $18.80 | Acquired | 595931 | Direct |
| 2024-11-05 | Common Stock | S | 96986 | $35 | Disposed | 498945 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-11-05 | Option (right to buy) | $18.80 | M | 96986 | Disposed | 2025-09-09 | Common Stock (96986) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 5835 | Indirect |
Footnotes
F1: Includes 288,932 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic
equivalent of one share of Common Stock.
F2: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023.
F3: Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of November 4, 2024.
F4: The option, representing the right to purchase a total of 96,986 shares of Common Stock, became fully exercisable on September 10, 2022.